Friday, 28 August 2026 SourcesAbout🌓
🇮🇳 IN ▾
BREAKING
India News

FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'

Hindustan Times - India News ·
FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'

The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.

Read the full article on Hindustan Times - India News ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.hindustantimes.com — the content belongs to Hindustan Times - India News.

More from Hindustan Times - India News

See all ›

More in India News

See all ›